Multiple Pulmonary Metastases of Recurrent Giant Cell Tumor of Bone with Expression of VEGFR-2 Successfully Controlled by Denosumab and Apatinib: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Multiple Pulmonary Metastases of Recurrent Giant Cell Tumor of Bone with Expression of VEGFR-2 Successfully Controlled by Denosumab and Apatinib: A Case Report and Literature Review

Published:2021-06 Issue: Volume:Volume 13 Page:4447-4454
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Gong Taojun,Luo Yi,Wang Yitian,Zheng Chuanxi,Fang Jianguo,Min Li^ORCID,Zhou Yong,Tu Chongqi^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference25 articles.

1. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

2. Giant Cell Tumor of Bone

3. Pulmonary metastasis of giant cell tumour: a retrospective study of three hundred and ten cases

4. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the mystery: A comprehensive review of multidisciplinary strategies for managing giant cell tumor of the bone;Journal of Orthopaedic Reports;2025-03

2. The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era;Current Oncology;2024-04-09

3. Case Report: Unresectable pulmonary metastases of a giant cell tumor of bone treated with denosumab: a case report and review of literature;Frontiers in Oncology;2023-08-16

4. Denosumab for giant cell tumors of bone from 2010 to 2022: a bibliometric analysis;Clinical and Experimental Medicine;2023-04-27

5. A Multiparametric Method Based on Clinical and CT-Based Radiomics to Predict the Expression of p53 and VEGF in Patients With Spinal Giant Cell Tumor of Bone;Frontiers in Oncology;2022-06-21